Skip to main content

J. Stephen Jones, MD, MBA, FACS

President and CEO, Inova Health System

Stephen previously served as President of Cleveland Clinic Regional Hospitals and Family Health Centers. He also served as Professor of Surgery at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. He was previously Department Chair and held the Leonard Horvitz and Samuel Miller Distinguished Chair in Urologic Oncology. This endowed chair has now been renamed the J. Stephen Jones Distinguished Chair in Urology Research, and is to be held in perpetuity by the sitting Cleveland Clinic Urology Department chair, currently Dr. Georges Pascal-Haber.

Stephen earned a Bachelor of Science degree in Zoology at the J. William Fulbright College of Arts & Sciences at the University of Arkansas and his medical degree at the University of Arkansas for Medical Sciences (UAMS). After residency at Vanderbilt University, he joined the Springfield Clinic/St. John’s Health System in Missouri. Under his chairmanship, the Department of Urological Surgery became the highest rated community urology program in America, according to U.S. News & World Report in 1999.

He has published over 200 peer-reviewed manuscripts and over 40 book chapters. The American Urological Association named him the next Editor of its journal, Urology Practice, in 2018. He has previously been Editor of Urology & Kidney Disease News, Associate Editor for Renal & Urology News and Urology, and has served on the Editorial Board of BJU International, formerly British Journal of Urology. He has published two books for the lay patient population and is editor of five medical textbooks. In 2010, Stephen earned the distinction of admittance to Beta Gamma Sigma, the International Business Honor Society, as one of the top-achieving 20% of business school graduates in the nation upon graduation from the Weatherhead School of Management at Case Western Reserve University.

Castle Connolly consistently lists him as one of America’s Top Doctors, signifying the top 1% of all cancer physicians in addition to the top 1% of urologists in the nation. He also was elected to the AMGA (American Medical Group Association) Board of Directors in 2015 and its executive committee in 2018.